Business Description
Omeros Corporation is a Seattle-based drug development company founded in 1994 that focuses on treatments for rare immune system diseases. Its most advanced drug candidate, Narsoplimab, targets a serious complication of stem cell transplants and has also been studied as a potential treatment for COVID-19. The company has several other medicines in various stages of testing, addressing conditions ranging from addiction and movement disorders to blood cancers and drug-resistant infections.
